Latest Period
Q4 2025
Security Snapshot
CARGO THERAPEUTICS, INC. - Common Stock, $0.001 par value (CRGX) Institutional Ownership
CUSIP: 14179K101
13F Institutional Holders and Ownership History from Q4 2023 to Q4 2025
Institutions Reporting
0
Shares (Excl. Options)
0
Price
$4.47
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
- Type / Class
- Equity / Common Stock, $0.001 par value
- Symbol
- CRGX
- Shares outstanding
- 10,000
- Price per share
- $4.47
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 0
- Total reported value
- $0
- Share change
- -161
- Value change
- -$720
- Number of holders
- 0
- Price from insider filings
- $4.47
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- CRGX - CARGO THERAPEUTICS, INC. - Common Stock, $0.001 par value is tracked under CUSIP 14179K101.
- 0 institutions reported positions in Q4 2025.
- 6 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 1 to 0 between Q3 2025 and Q4 2025.
- Reported value moved from $720 to $0.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 0 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 14179K101?
CUSIP 14179K101 identifies CRGX - CARGO THERAPEUTICS, INC. - Common Stock, $0.001 par value in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 14179K101:
Significant Owners of CARGO THERAPEUTICS, INC. - Common Stock, $0.001 par value (CRGX) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 7.3% | $15,655,313 | 3,381,277 | Cormorant Asset Management, LP | 31 Mar 2025 | |||
| PERCEPTIVE ADVISORS LLC | 2.5% | $5,420,850 | 1,170,810 | Perceptive Advisors LLC | 23 Apr 2025 | |||
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.3% | $2,767,268 | 597,682 | T. Rowe Price Associates, Inc. | 31 Mar 2025 | |||
| TANG CAPITAL MANAGEMENT LLC | 100% | +1334% | $44,700 | -$13,631,846 | 10,000 | -100% | TANG CAPITAL MANAGEMENT, LLC | 19 Aug 2025 |
| JANUS HENDERSON GROUP PLC | 0% | -103% | $36,577 | -$13,068,842 | 7,900 | -100% | JANUS HENDERSON GROUP PLC | 31 Mar 2025 |
| FMR LLC | 0% | -100% | $33,030 | -$31,715,748 | 7,196 | -100% | FMR LLC | 31 Jul 2025 |
As of 31 Dec 2025, 0 institutional investors reported holding 0 shares of CARGO THERAPEUTICS, INC. - Common Stock, $0.001 par value (CRGX). This represents 0% of the company’s total 10,000 outstanding shares.
Institutional Holders of CARGO THERAPEUTICS, INC. - Common Stock, $0.001 par value (CRGX) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 0 | $0 | -$720 | $4.47 | 0 |
| 2025 Q3 | 161 | $720 | -$196,029,529 | $4.47 | 1 |
| 2025 Q2 | 47,704,899 | $196,545,511 | +$5,706,427 | $4.12 | 113 |
| 2025 Q1 | 46,295,165 | $188,426,907 | -$114,782,734 | $4.07 | 112 |
| 2024 Q4 | 54,177,369 | $781,282,216 | +$23,849,074 | $14.42 | 97 |
| 2024 Q3 | 46,804,442 | $865,135,088 | +$39,819,756 | $18.45 | 78 |
| 2024 Q2 | 43,624,607 | $716,303,723 | +$117,052,338 | $16.42 | 71 |
| 2024 Q1 | 36,387,034 | $811,903,367 | +$29,356,109 | $22.32 | 65 |
| 2023 Q4 | 34,977,826 | $809,128,383 | +$808,506,197 | $23.15 | 44 |